Psyence Biomedical PBM
NASDAQ PBM
$4.16 +0.04 (+0.97%)
At close: Oct 23, 2026 · 4:00 PM EDT

Psyence Biomedical (PBM) Return on Sales [ROS] (2025)

Updated

Psyence Biomedical's Return on Sales [ROS] was -18.01% in the quarter ended Sep 30, 2023.

Analysis

Psyence Biomedical (PBM) Return on Sales [ROS] (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Psyence Biomedical 2.30 Mn -20.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -2,144.14%
API Access

Psyence Biomedical Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PBM&period=max&api_key=YOUR_API_KEY